faricimab: Clinical Trials

3 trials of faricimab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Recruiting 1
Phase 21Completed 1

Follow faricimab: new trials by email Literature Review of faricimab trials Research Report on faricimab

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
RO7823653, Faricimab - Diabetic Macular Edema
Phase 1RecruitingGenentech, Inc.932026-04-212026-11-09
A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and Exploratory Efficacy of Intravitreal OLN324
Faricimab, OLN324 - Diabetic Macular Edema (DME), Neovascular (Wet) Age-Related Macular Degeneration
Phase 1CompletedOllin Biosciences, Inc.1642025-02-122026-03-19
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema
RO7446603, Aflibercept, Faricimab - Diabetic Macular Edema
Phase 1 / Phase 2CompletedGenentech, Inc.3882022-06-222026-06-23

Conditions studied

Macular Degeneration (1)

Sponsors

Genentech, Inc. (2)  ·  Ollin Biosciences, Inc. (1)

Countries

United States (3)  ·  Puerto Rico (2)  ·  China (1)